Search results
Results from the WOW.Com Content Network
The Saskatchewan Health Authority is the single health region of the province of Saskatchewan.It is a health authority providing direct and contracted health services including primary, secondary, tertiary and quaternary care, home and community care, mental health services, population and preventive health and addictions services to the people of Saskatchewan.
A study of 236,379 COVID-19 survivors showed that the "estimated incidence of a neurological or psychiatric diagnosis in the following 6 months" after diagnosed infection was 33.62% with 12.84% "receiving their first such diagnosis" and higher risks being associated with COVID-19 severity.
The pandemic has also negatively impacted mental health globally, including increased loneliness resulting from social distancing [14] and depression and domestic violence from lockdowns. [15] As of June 2020, 40% of U.S. adults were experiencing adverse mental health symptoms, with 11% having seriously considered to attempt suicide. [16]
An infographic from the World Health Organization showing statistics related to the impact of COVID-19 on mental health. COVID-19 lockdowns were first used in China and later worldwide by national and state governments. [157] Most workplaces, schools, and public places were closed. Lockdowns closed most mental health centers.
In December 2020, Health Canada approved clinical trials for a new COVID-19 subunit vaccine developed by the University of Saskatchewan Vaccine and Infectious Disease Organization–International Vaccine Centre (VIDO–InterVac), which were expected to begin in January 2021 at the Canadian Center for Vaccinology in Halifax as a combined phase 1 ...
The COVID-19 pandemic in Bolivia was a part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was confirmed to have spread to Bolivia on 10 March 2020, when its first two cases were confirmed in the departments of Oruro and Santa Cruz .
During the COVID-19 pandemic, the Government of Saskatchewan has provided $4.2 million to VIDO. [13] It also received $23 million in federal funding announced on March 23, 2020 for the centre's manufacturing facility to produce COVID-19 vaccines for clinical trials, and for overall operational costs. [14]
The WHO has developed a multinational coalition of vaccine scientists defining a Global Target Product Profile (TPP) for COVID-19, identifying favorable attributes of safe and effective vaccines under two broad categories: "vaccines for the long-term protection of people at higher risk of COVID-19, such as healthcare workers", and other ...